Dr Reddy’s Lab Gets USFDA Nod For XEGLYZE Lotion
Hyderabad, July 27 (Hydnow): Dr. Reddy’s Laboratories said approval of XEGLYZE (abametapir) lotion, 0.74%, a 505(b)(1) NDA by the U.S. Food and Drug Administration (USFDA). The approval triggers the contractual…